These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33677866)

  • 21. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome.
    Sciascia S; Radin M; Cecchi I; Rubini E; Bazzan M; Roccatello D
    Semin Arthritis Rheum; 2019 Feb; 48(4):741-744. PubMed ID: 29747993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
    Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
    Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
    Front Immunol; 2018; 9():2644. PubMed ID: 30524428
    [No Abstract]   [Full Text] [Related]  

  • 25. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.
    Stojanovich L; Djokovic A; Stanisavljevic N; Zdravkovic M
    Lupus; 2018 Apr; 27(5):858-863. PubMed ID: 29301476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and analytical manifestations of primary antiphospholipid antibody syndrome].
    Camps García MT; Gutiérrez Rueda A; Guil García M; Perelló-González Moreno I; García Portales R; Belmonte López A; de Rámon Garrido E
    An Med Interna; 1993 Dec; 10(12):576-82. PubMed ID: 8049321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
    Rosa RF; Ugolini-Lopes MR; Gandara APR; Vendramini MBG; Campanholo KR; Dutra L; de Andrade DCO
    Rheumatology (Oxford); 2021 Jan; 60(1):179-187. PubMed ID: 32613245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort.
    Franco AMM; Makita LS; Perrut VC; Balbi GGM; Barros AM; Medina FMC; Signorelli F
    Lupus; 2023 Feb; 32(2):180-188. PubMed ID: 36444940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of pregnancies in women with suspected antiphospholipid syndrome.
    Nili F; McLeod L; O'Connell C; Sutton E; McMillan D
    J Neonatal Perinatal Med; 2013; 6(3):225-30. PubMed ID: 24246594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.
    de Carvalho JF; Pasoto SG; Appenzeller S
    Clin Dev Immunol; 2012; 2012():981519. PubMed ID: 22489254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia in the antiphospholipid syndrome.
    Cuadrado MJ; Mujic F; Muñoz E; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Mar; 56(3):194-6. PubMed ID: 9135225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications.
    Shi Y; Zhao J; Jiang H; Huang C; Qi W; Song Y; Wang Q; Li M; Tian X; Zhao Y; Zeng X
    Rheumatology (Oxford); 2022 Dec; 62(1):256-263. PubMed ID: 35536236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.
    Comellas-Kirkerup L; Hernández-Molina G; Cabral AR
    Blood; 2010 Oct; 116(16):3058-63. PubMed ID: 20625007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies.
    Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L
    Lupus; 1997; 6(3):261-7. PubMed ID: 9104734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
    Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
    Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome.
    Galindo M; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 1999 Sep; 38(9):848-53. PubMed ID: 10515646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.